Virax Share Price

Virax Share Price

NASDAQ: VRAX | Others
$0.42
-$0.02 (-4.54%) Last updated on 19 Nov, 2026 | 03:11 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Virax Stock Performance

Open
$0.45
Prev. Close
$0.44
Circuit Range
N/A
Day Range
$0.43 - $0.49
Year Range
$0.10 - $13.18
Volume
905
Average Traded
$0.46

Virax Share Price Today

As of 19 November 2026, Virax Biolabs Group Limited's share price is $0.42. The stock opened at $0.45, compared to its previous close of $0.44. During today's trading session, Virax Biolabs Group Limited's share price traded between $0.43 and $0.49, with an average price of $0.46. Over the past 52 weeks, the stock has recorded a high of $13.18 and a low of $0.10. In terms of performance, Virax Biolabs Group Limited's share price has risen by 129.62% over the last six months and is up 6.38% on a year-on-year basis.

Virax Share Price Chart

Line chart of the Virax price trend over the selected period. The price fell overall, ranging from 0.42 to 0.49, ending at 0.42.
$0.43$0.49
L
Show Current Price
H

Virax Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$10.00M
Return On Equity (TTM)
N/A
Profit Margin
-50200.00%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Virax Annual Profit & Loss

All figures in USD

Particulars2023202420252026
Revenue$0.01$0.16$0.01$0.01
Net Profit-$5.46-$6.73-$6.06-$5.02
Net Profit Margin-54600.00%-4206.25%-60600.00%-50200.00%
Income ChangeN/A-23.26%9.96%17.16%

Virax Balance Sheet

All figures in USD Million

Particulars2026202520242023
Non Current Assets1.51.531.10.18
Current Assets6.834.894.389.63
Total Assets8.326.435.489.81
Non Current Liabilities0.30.290.180.0
Current Liabilities0.690.670.170.91
Total Liabilities0.990.960.350.91
Shareholders' Equity7.335.465.148.9

Virax Cash Flow

Annually

All figures in USD Million

Particulars2026202520242023
Operating-4.62-4.56-6.4-4.18
Investing-0.26-0.6-1.16-0.18
Financing7.095.811.813.69

Corporate Actions

Split
Ex-date: 14 Dec 2026

Split
Ex-date: 26 Jun 2026

Split
Ex-date: 18 Dec 2023

About Virax

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Virax Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.17
$0.43
-66.64%
Oct 2026
$2.23
$1.28
-41.82%
Sep 2026
$2.76
$2.20
-24.66%
Aug 2026
$2.78
$2.92
-2.01%
Jul 2026
$2.64
$2.98
+1.19%
Jun 2026
$0.19
$2.94
+1,509.29%
May 2026
$0.13
$0.18
+41.86%
Apr 2026
$0.18
$0.13
-40.28%
Mar 2026
$0.22
$0.22
-1.37%
Feb 2026
$0.28
$0.22
-20.07%
Jan 2026
$0.39
$0.27
-29.02%
Dec 2025
$0.40
$0.39
-2.28%

Virax Share Price FAQs